The FDA cited the telehealth company for making statements on its website that were false or misleading, including claims that its products were weekly injectable GLP-1 with the same active ingredient as Ozempic and Wegovy and contained clinically proven ingredients. In the warning letter, dated September 9, the agency emphasized that compounded drug products are not FDA-approved, and Hims & Hers statements implied equivalency to FDA-approved medications, which is not accurate
Foods 12 (8), 1645 (2023) P.L
Always complete one medication cycle before starting the other, with your providers guidance
GLP-1 RAs and risk of nonarteritic anterior ischemic optic neuropathy in older patients with diabetes
Exercise Physical activity is tailored to your preferences, fitness level, and schedule
If attaching a video or photo, terms of use apply.